Table 1. LMO2 expression in tumors and their corresponding normal tissues (data from TCGA Pan-cancer dataset).
| Tumor type | Mean value of normalized LMO2 expression level (Sample counts) |
Statistical significance (*p < 0.05 [Student’s t-test]) | |
|---|---|---|---|
| Primary tumors | Normal tissues | ||
| Glioblastoma | 2.356 (n = 154) | 1.201 (n = 5) | * |
| Pheochromocytoma and paraganglioma | 0.685 (n = 179) | 0.569 (n = 3) | |
| Thymoma | 1.233 (n = 119) | 0.292 (n = 2) | |
| Thyroid cancer | 0.270 (n = 505) | 0.469 (n = 59) | |
| Sarcoma | 0.381 (n = 258) | 1.274 (n = 2) | |
| Head and neck cancer | −0.952 (n = 519) | 0.337 (n = 43) | * |
| Breast cancer | −0.320 (n = 1090) | 1.001 (n = 113) | * |
| Cervical cancer | −0.696 (n = 303) | 1.523 (n = 3) | * |
| Endometrial cancer | 0.779 (n = 174) | 1.599 (n = 24) | * |
| Prostate cancer | −0.775 (n = 497) | −0.210 (n = 52) | * |
| Liver cancer | −0.413 (n = 371) | −0.314 (n = 50) | |
| Bile duct cancer | −0.743 (n = 36) | −0.411 (n = 9) | |
| Pancreatic cancer | 0.226 (n = 178) | 0.826 (n = 4) | |
| Colon cancer | −1.666 (n = 286) | −0.206 (n = 41) | * |
| Rectal cancer | −1.508 (n = 94) | −0.110 (n = 9) | * |
| Lung adenocarcinoma | −0.521 (n = 508) | 1.477 (n = 58) | * |
| Lung squamous cell carcinoma | −0.824 (n = 502) | 1.477 (n = 51) | * |
| Kidney chromophobe | −0.147 (n = 66) | 1.681 (n = 25) | * |
| Kidney clear cell carcinoma | 1.328 (n = 529) | 1.656 (n = 72) | * |
| Kidney papillary cell carcinoma | 0.187 (n = 290) | 1.490 (n = 32) | * |
| Bladder cancer | −0.336 (n = 407) | 0.094 (n = 19) | |
| Melanoma | −1.470 (n = 103) | 0.602 (n = 1) | |